Phosphodiesterase 4 (PDE4) Inhibitors in the Treatment of COPD: Promising Drug Candidates and Future Directions

By  

Current Medicinal Chemistry, Vol. 23, Iss. 2, 2016-01 ,pp. : 129-141

Bentham Science Publishers

Access to resources Recommend Favorite

Phosphodiesterase-4 as a potential drug target

By Zhang Kam YJ   Ibrahim Prabha N   Gillette Sam   Bollag Gideon  

Expert Opinion on Therapeutic Targets, Vol. 9, Iss. 6, 2005-12 ,pp. : 1283-1305

Informa Healthcare

Access to resources Recommend Favorite

Phosphodiesterase (PDE)4 inhibitors: anti-inflammatory drugs of the future?

By Teixeira M.M.   Gristwood R.W.   Cooper N.   Hellewell P.G.  

Trends in Pharmacological Sciences, Vol. 18, Iss. 5, 1997-05 ,pp. : 164-170

Elsevier

Access to resources Recommend Favorite

Behavioral and neurochemical characterization of mice deficient in the phosphodiesterase-4B (PDE4B) enzyme

By Siuciak Judith   McCarthy Sheryl   Chapin Douglas   Martin Ashley  

Psychopharmacology, Vol. 197, Iss. 1, 2008-03 ,pp. : 115-126

Springer Publishing Company

Access to resources Recommend Favorite

Antipsychotic profile of rolipram: efficacy in rats and reduced sensitivity in mice deficient in the phosphodiesterase-4B (PDE4B) enzyme

By Siuciak Judith   Chapin Douglas   McCarthy Sheryl   Martin Ashley  

Psychopharmacology, Vol. 192, Iss. 3, 2007-06 ,pp. : 415-424

Springer Publishing Company

Access to resources Recommend Favorite